Pharmacological evidence supports the role of 5-HT2 receptors in the modulation of anxiety and depression, and non-selective antagonists such as ritanserin and ketanserin are anxiolytic in rodents (Griebel et al., 1997, Nic Dhonnchadha et al., 2003). The gene discussed is HTR2A; the disease is major depressive disorder.